vinay prasad center for biologics evaluation and research - Search News

News

FDA names Dr. Vinay Prasad

Vinay Prasad tapped to run FDA center that regulates vaccines, gene therapies

Vinay Prasad will be the next director of the FDA's Center for Biologics Evaluation and Research, after Peter Marks was forced out.

CNN on MSN · 1d

FDA chooses Dr. Vinay Prasad to lead biologics, vaccines division

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics Evaluation and Research, the division that oversees vaccines and biologic medicines.

Medical Xpress · 22h

Dr. Vinay Prasad to head FDA vaccine, biologics division

The U.S. Food and Drug Administration (FDA) has chosen Dr. Vinay Prasad, a professor at the University of California-San Francisco, to lead its Center for Biologics Evaluation and Research.

Axios on MSN2h

Vinay Prasad believes that the FDA too often has acted as a rubber stamp for pharma, both big and small.

Biotech venture capital is risky business, inherently at the mercy of regulators and binary outcomes. Now it may face a new ...

MedPage Today28mOpinion

Vinay Prasad Speaks to CBER Staff: Which Prasad Showed Up?

Vinay Prasad, MD, MPH, the newly appointed Director of the FDA's Center for Biologics Evaluation and Research (CBER), ...

BioPharma Dive2h

Biotech is guessing how Vinay Prasad might change the FDA. His research, writing offer clues.

CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...

New CBER Director Vinay Prasad praises evidence, FDA reviewers in first speech to staff

WASHINGTON — In his first address to FDA staff on Wednesday, Vinay Prasad emphasized his commitment to evidence, his ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results